PL3071192T3 - Związek kurkufenol do zastosowania w leczeniu nowotworu - Google Patents
Związek kurkufenol do zastosowania w leczeniu nowotworuInfo
- Publication number
- PL3071192T3 PL3071192T3 PL14815145T PL14815145T PL3071192T3 PL 3071192 T3 PL3071192 T3 PL 3071192T3 PL 14815145 T PL14815145 T PL 14815145T PL 14815145 T PL14815145 T PL 14815145T PL 3071192 T3 PL3071192 T3 PL 3071192T3
- Authority
- PL
- Poland
- Prior art keywords
- treating cancer
- curcuphenol compound
- curcuphenol
- compound
- cancer
- Prior art date
Links
- BTXSROVNGICYFE-UHFFFAOYSA-N (+)-curcuphenol Natural products CC(C)=CCCC(C)C1=CC=C(C)C=C1O BTXSROVNGICYFE-UHFFFAOYSA-N 0.000 title 1
- -1 Curcuphenol compound Chemical class 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361906817P | 2013-11-20 | 2013-11-20 | |
| EP14815145.9A EP3071192B1 (en) | 2013-11-20 | 2014-11-20 | Curcuphenol compound for use in treating cancer |
| PCT/US2014/066543 WO2015077411A1 (en) | 2013-11-20 | 2014-11-20 | Curcuphenol compounds for increasing mhc-i expression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3071192T3 true PL3071192T3 (pl) | 2020-06-29 |
Family
ID=52117996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14815145T PL3071192T3 (pl) | 2013-11-20 | 2014-11-20 | Związek kurkufenol do zastosowania w leczeniu nowotworu |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US20150147314A1 (pl) |
| EP (2) | EP3639815A1 (pl) |
| JP (4) | JP6560215B2 (pl) |
| CN (1) | CN106456572A (pl) |
| CA (1) | CA2930156C (pl) |
| DK (1) | DK3071192T3 (pl) |
| ES (1) | ES2775577T3 (pl) |
| HU (1) | HUE049301T2 (pl) |
| PL (1) | PL3071192T3 (pl) |
| WO (1) | WO2015077411A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3071192T3 (da) | 2013-11-20 | 2020-03-16 | Cava Healthcare Inc | Curcuphenolforbindelse til anvendelse i behandling af cancer |
| US20170020854A1 (en) * | 2015-07-22 | 2017-01-26 | Teva Pharmaceuticals International Gmbh | Pridopidine base formulations and their use |
| WO2020131911A1 (en) * | 2018-12-17 | 2020-06-25 | Intra-Cellular Therapies, Inc. | Substituted heterocycle fused gamma-carbolines synthesis |
| CN113906006A (zh) * | 2019-01-31 | 2022-01-07 | 卡瓦医疗保健公司 | 用于增加mhc-i表达和调节组蛋白去乙酰化酶活性的化合物 |
| TW202214244A (zh) * | 2020-08-10 | 2022-04-16 | 國立彰化師範大學 | 具有協同抗癌功效之氯硝柳胺（Ｎｉｃｌｏｓａｍｉｄｅ）和雙硫侖（Ｄｉｓｕｌｆｉｒａｍ）醫藥組合物及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6261939A (ja) * | 1985-09-10 | 1987-03-18 | Yamanouchi Pharmaceut Co Ltd | クルクフエノ−ル誘導体及びこれを含有する医薬 |
| KR100439425B1 (ko) * | 2001-03-22 | 2004-07-05 | (주)바이오케어 | 잔토리졸을 포함하는 조성물 및 그 용도 |
| CN1842326A (zh) * | 2003-06-24 | 2006-10-04 | 生物关怀有限公司 | 癌症化疗药物所引起的毒性的抑制剂以及含有该抑制剂的癌症化疗药物组合物 |
| WO2008144880A1 (en) * | 2007-05-31 | 2008-12-04 | F.P.L. Pharma Inc. | Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof |
| DK3071192T3 (da) | 2013-11-20 | 2020-03-16 | Cava Healthcare Inc | Curcuphenolforbindelse til anvendelse i behandling af cancer |
-
2014
- 2014-11-20 DK DK14815145.9T patent/DK3071192T3/da active
- 2014-11-20 JP JP2016533609A patent/JP6560215B2/ja active Active
- 2014-11-20 ES ES14815145T patent/ES2775577T3/es active Active
- 2014-11-20 WO PCT/US2014/066543 patent/WO2015077411A1/en active Application Filing
- 2014-11-20 US US14/548,726 patent/US20150147314A1/en not_active Abandoned
- 2014-11-20 PL PL14815145T patent/PL3071192T3/pl unknown
- 2014-11-20 CN CN201480072728.3A patent/CN106456572A/zh active Pending
- 2014-11-20 EP EP19216024.0A patent/EP3639815A1/en active Pending
- 2014-11-20 HU HUE14815145A patent/HUE049301T2/hu unknown
- 2014-11-20 EP EP14815145.9A patent/EP3071192B1/en active Active
- 2014-11-20 CA CA2930156A patent/CA2930156C/en active Active
-
2017
- 2017-01-25 US US15/415,291 patent/US10751296B2/en active Active
-
2019
- 2019-07-18 JP JP2019132434A patent/JP2019196380A/ja not_active Withdrawn
-
2020
- 2020-08-20 US US16/998,072 patent/US11197832B2/en active Active
-
2021
- 2021-04-06 JP JP2021064761A patent/JP7071570B2/ja active Active
- 2021-11-08 US US17/521,674 patent/US12011421B2/en active Active
-
2022
- 2022-05-09 JP JP2022076869A patent/JP2022093724A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3071192A1 (en) | 2016-09-28 |
| US20170319508A1 (en) | 2017-11-09 |
| DK3071192T3 (da) | 2020-03-16 |
| JP2016539129A (ja) | 2016-12-15 |
| JP7071570B2 (ja) | 2022-05-19 |
| JP6560215B2 (ja) | 2019-08-14 |
| CA2930156C (en) | 2023-11-07 |
| EP3639815A1 (en) | 2020-04-22 |
| WO2015077411A1 (en) | 2015-05-28 |
| JP2019196380A (ja) | 2019-11-14 |
| EP3071192B1 (en) | 2019-12-18 |
| US11197832B2 (en) | 2021-12-14 |
| US20200375917A1 (en) | 2020-12-03 |
| US12011421B2 (en) | 2024-06-18 |
| CN106456572A (zh) | 2017-02-22 |
| US20220062195A1 (en) | 2022-03-03 |
| JP2021100982A (ja) | 2021-07-08 |
| CA2930156A1 (en) | 2015-05-28 |
| ES2775577T3 (es) | 2020-07-27 |
| JP2022093724A (ja) | 2022-06-23 |
| HUE049301T2 (hu) | 2020-09-28 |
| US10751296B2 (en) | 2020-08-25 |
| US20150147314A1 (en) | 2015-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL245731A0 (en) | Combined treatment for cancer | |
| IL245281A0 (en) | Methods and preparations for the treatment of cancer | |
| HK1220155A1 (zh) | 治療癌症的方法 | |
| SG11201603050TA (en) | Methods for treating cancers | |
| GB201322725D0 (en) | Cancer therapy | |
| IL244353A0 (en) | Compounds and use for cancer treatment | |
| GB2516814B (en) | Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer | |
| HK1220900A1 (zh) | 癌症的治療 | |
| SG11201507847UA (en) | Cancer therapy | |
| HRP20182041T1 (hr) | Pripravci oksprenolola za liječenje raka | |
| HK1225647A1 (zh) | 用於治療癌症的組合物和方法 | |
| HK1215195A1 (zh) | 基於 分層的癌症治療 | |
| PT3016682T (pt) | Métodos para tratamento do cancro | |
| HK1223547A1 (zh) | 癌症治療方法 | |
| HUE049301T2 (hu) | Kurkofenol-vegyület rák kezelésére | |
| HK1210136A1 (en) | Ingenol-derived compounds that can be used for treating cancer | |
| EP2961412A4 (en) | CANCER THERAPY | |
| HK1202453A1 (en) | Therapeutic composition for treating cancers | |
| EP2971044A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER | |
| PL3016948T3 (pl) | 2-acyloaminotiazole do leczenia nowotworów | |
| GB201300546D0 (en) | Cancer Treatment | |
| GB201321531D0 (en) | Treatment for cancers | |
| GB201322764D0 (en) | Treating places | |
| GB201317213D0 (en) | Cancer Therapy | |
| GB201322958D0 (en) | Uses of oligouronates in cancer treatment |